Security key
97382D600
WINDTREE THERAPEUTICS INC /DE/ - COM NEW (WINT)
CUSIP: 97382D600
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 45,265
- Total 13F value
- $57,034
- Share change
- +45,265
- SEC-reported price per share
- $1.26
- Number of holders
- 5
- Value change
- +$57,034
- Number of buys
- 5
Report period
Q1 2025
Institutions
5
Top holders
5
WINT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
WINDTREE THERAPEUTICS INC /DE/ SEC filings
WINDTREE THERAPEUTICS INC /DE/ company facts
Broader feeds
Reporting periods
Holder history for CUSIP 97382D600
Recent filing periods:
Ownership snapshot
Top reported holders of WINT - WINDTREE THERAPEUTICS INC /DE/ - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
James Huang
Comparable rows
1/15
Latest evidence
31 Dec 2024
13D/G
3/4/5
13F
Lead comparable stake: 2.6%
14 rows are not safely comparable across share classes.
13D/G row: ARMISTICE CAPITAL, LLC
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 2.6%.
1 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 1
ARMISTICE CAPITAL, LLC
2.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
2.6%
Reported 13D/G
· 31 Dec 2024
|
$28,855
288,552 shares
|
$0 | 31 Dec 2024 |
| Center Laboratories, Inc. |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
$2,527,492
2,782,352 shares
mixed-class rows
|
— | 20 May 2020 |
| Bioengine Capital Inc. |
3/4/5
10%+ Owner
|
—
mixed-class rows
|
—
304,176 shares
mixed-class rows
|
— | 20 May 2020 |
| James Huang |
3/4/5
Director
|
—
mixed-class rows
|
$3,819,976
5,970,058 shares
mixed-class rows
|
— | 22 Feb 2023 |
| John P. Hamill |
3/4/5
SVP & CFO
|
—
denominator unverified
|
$74,249
72,800 shares
|
— | 26 Jul 2022 |
| Craig Fraser |
3/4/5
President and CEO, Director
|
—
mixed-class rows
|
$59,032
12,669 shares
mixed-class rows
|
— | 08 Oct 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
5
Shares
45,265
Rows available
5
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
5
Q1 2025 holders
5
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend